2Doetsch AM,Faber J, Lynnerup N, et al. The effect of calcium and vita- min D3 supplementation on the healing of the proximal humerus fracture : a randomized placebo-controlled study [ J ]. Calcif Tissue Int, 2004 ; 75 : 183-8.
3Lyritis GP, Trovas G. Analgesic effects of calcitonin [ J ]. Bone, 2002 ; 30 (5):71-4.
4Knopp JA, Diner BM, Blitz M, et al. Calcitonin for treating acute pain of osteoporotic vertebral compression fractures : a systematic review of ran- domized, controlled trials [ J]. Osteoporos Int,2005 ; 16 ( 10 ) : 1281-90.
5Lyritis G, Boscainos PJ. Calcitonin effects on cartilage and fracture heal- ing [ J ]. J Musculoskelet Neuronal Interact,2001 ; 2 ( 2 ) : 137 -42.
6Karachalios T, Lyritis GP, Kaloudis J, et al. The effects of calcitonin on a- cute bone loss after pertrochanteric fractures, a prospective, randomised trial [ J ]. J Bone Joint Surg Br,2004 ; 86 ( 3 ) : 350 -8.
7Huusko TM, Karppi P. Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture [ J]. Calcif Tissue Int,2002 ;71 (6) :478-84.
8Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women withosteoporosis: the fracture intervention trial [ J]. J Clin Endocrinol Metab,2000 ;85:4118-24.
9Lyles KW, Colon-Emeric CS, Magaziner JS, et al. Zoledronic Acid and Clinical Fractures andMortality after Hip Fracture [ J ]. N Engl J Med, 2007 ;357 ( 18 ) : 1799-809.
10Cao Y, Mori S. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats [ J ). J Bone Miner Res,2002;17(12):2237-46.
8Melton LJ 3rd,Cooper C. Magnitude and impact of osteoporosis and fractures [M]//Marcus R, Feldman D, Kelsey J. Osteoporosis. 2nd ed. San Diego: Academic Press, 2001 .. 557-567.
9Sahota O ,Worley A ,Hosking DJ. An audit of current clinical practice in the management of osteoporosis in Nottingham [J]. J Public Health Med, 2000,22 (4): 466-472.
10Genant HK, Cooper C, Poor G, et al. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis [J]. Osteoporos Int, 1999,10(4) : 259-264.
